Lower heart rate in patients with acute heart failure: the role of left ventricular ejection fraction.

Heart rate acute heart failure chronotropic incompetence heart failure with preserved ejection fraction supranormal left ventricular ejection fraction

Journal

Scandinavian cardiovascular journal : SCJ
ISSN: 1651-2006
Titre abrégé: Scand Cardiovasc J
Pays: England
ID NLM: 9708377

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 8 8 2024
pubmed: 8 8 2024
entrez: 8 8 2024
Statut: ppublish

Résumé

The clinical impact of heart rate (HR) in heart failure with preserved ejection fraction (HFpEF) is a matter of debate. Among those with HFpEF, chronotropic incompetence (CI) has emerged as a pathophysiological mechanism linked to the severity of the disease. In this study, we sought to evaluate whether admission heart rate in acute heart failure differs along left ventricular ejection fraction (LVEF). We included retrospectively 3,712 consecutive patients admitted for acute heart failure (AHF) in the Cardiology department of a third level center. HR values were assessed at presentation. LVEF was assessed by transthoracic echocardiogram during the index admission and stratified into four categories: reduced ejection fraction ( The mean age of the sample was 73,9 ± 11.3 years, 1,734 (47,4%) were women, and 1,214 (33,2%), 570 (15,6%), 1,229 (33,6%) and 648 (17,7%) patients showed LVEF HR at admission for AHF is a predictor of LVEF but only in patients with sinus rhythm.

Sections du résumé

BACKGROUND UNASSIGNED
The clinical impact of heart rate (HR) in heart failure with preserved ejection fraction (HFpEF) is a matter of debate. Among those with HFpEF, chronotropic incompetence (CI) has emerged as a pathophysiological mechanism linked to the severity of the disease. In this study, we sought to evaluate whether admission heart rate in acute heart failure differs along left ventricular ejection fraction (LVEF).
METHODS UNASSIGNED
We included retrospectively 3,712 consecutive patients admitted for acute heart failure (AHF) in the Cardiology department of a third level center. HR values were assessed at presentation. LVEF was assessed by transthoracic echocardiogram during the index admission and stratified into four categories: reduced ejection fraction (
RESULTS UNASSIGNED
The mean age of the sample was 73,9 ± 11.3 years, 1,734 (47,4%) were women, and 1,214 (33,2%), 570 (15,6%), 1,229 (33,6%) and 648 (17,7%) patients showed LVEF
CONCLUSION UNASSIGNED
HR at admission for AHF is a predictor of LVEF but only in patients with sinus rhythm.

Identifiants

pubmed: 39115187
doi: 10.1080/14017431.2024.2386977
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2386977

Auteurs

Miguel Lorenzo (M)

Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Instituto de Investivación Sanitaria INCLIVA, Valencia, Spain.

Gema Miñana (G)

Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Instituto de Investivación Sanitaria INCLIVA, Valencia, Spain.
Universitat de València, Valencia, Spain.
CIBER Cardiovascular, Valencia, Spain.

Patricia Palau (P)

Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Instituto de Investivación Sanitaria INCLIVA, Valencia, Spain.
Universitat de València, Valencia, Spain.

Gonzalo Núñez (G)

Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Instituto de Investivación Sanitaria INCLIVA, Valencia, Spain.

Rafael de la Espriella (R)

Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Instituto de Investivación Sanitaria INCLIVA, Valencia, Spain.

Enrique Santas (E)

Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Instituto de Investivación Sanitaria INCLIVA, Valencia, Spain.
Universitat de València, Valencia, Spain.

Sandra Villar (S)

Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Instituto de Investivación Sanitaria INCLIVA, Valencia, Spain.

Victor Donoso (V)

Cardiology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Eduardo Núñez (E)

Instituto de Investivación Sanitaria INCLIVA, Valencia, Spain.

Juan Sanchis (J)

Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Instituto de Investivación Sanitaria INCLIVA, Valencia, Spain.
Universitat de València, Valencia, Spain.
CIBER Cardiovascular, Valencia, Spain.

Antoni Bayés-Genis (A)

CIBER Cardiovascular, Valencia, Spain.
Cardiology Department, Hospital Germans Trias i Pujol, Badalona, Spain.

Julio Núñez (J)

Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Instituto de Investivación Sanitaria INCLIVA, Valencia, Spain.
Universitat de València, Valencia, Spain.
CIBER Cardiovascular, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH